ARS Pharmaceuticals, Inc. SEC filings SPRY
ARS Pharmaceuticals, Inc. has 549 filings in SEC EDGAR's recent list, going back to Apr 12, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 3 | Initial insider ownership | Nov 4, 2026 | Oct 26, 2026 |
| 144 | Notice of proposed sale | Oct 30, 2026 | — |
| 144 | Notice of proposed sale | Oct 19, 2026 | — |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 144 | Notice of proposed sale | Sep 30, 2026 | — |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 144 | Notice of proposed sale | Sep 3, 2026 | — |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Sep 1, 2026 | — |
| 144 | Notice of proposed sale | Aug 31, 2026 | — |
| 144 | Notice of proposed sale | Aug 20, 2026 | — |
| 144 | Notice of proposed sale | Aug 20, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| 3 | Initial insider ownership | Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2026 | Jul 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 14, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 12, 2026 |
| 144 | Notice of proposed sale | Jun 12, 2026 | — |
| 144 | Notice of proposed sale | Jun 12, 2026 | — |
| 3 | Initial insider ownership | Jun 1, 2026 | Jun 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Officer or director change
|
May 13, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 31, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 24, 2026 | — |
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 144 | Notice of proposed sale | Nov 13, 2025 | — |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 144/A | Filing | Nov 12, 2025 | — |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 1, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Aug 28, 2025 | Aug 13, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 21, 2025 | Aug 19, 2025 |
| 144 | Notice of proposed sale | Aug 21, 2025 | — |
| 144 | Notice of proposed sale | Aug 21, 2025 | — |
| 144 | Notice of proposed sale | Aug 19, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 1, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 22, 2025 | — |
| 4 | Insider transaction | Jul 3, 2025 | Jul 1, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 2, 2025 | — |
| 4 | Insider transaction | Jul 1, 2025 | Jun 27, 2025 |
| 144 | Notice of proposed sale | Jul 1, 2025 | — |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 144 | Notice of proposed sale | Jun 18, 2025 | — |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| 144 | Notice of proposed sale | May 20, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Material agreement
|
May 2, 2025 | May 2, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 7, 2025 |
| 144 | Notice of proposed sale | Apr 7, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 24, 2025 | — |
| 4 | Insider transaction | Mar 21, 2025 | Mar 20, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 5, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Feb 4, 2025 | Feb 3, 2025 |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| S-3ASR | Automatic shelf registration | Jan 31, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 6, 2025 |
| 144 | Notice of proposed sale | Jan 6, 2025 | — |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 13, 2024 | Dec 11, 2024 |
| 144 | Notice of proposed sale | Dec 13, 2024 | — |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 144 | Notice of proposed sale | Dec 12, 2024 | — |
| 4 | Insider transaction | Dec 11, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 11, 2024 | Dec 10, 2024 |
| 144 | Notice of proposed sale | Dec 11, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 144 | Notice of proposed sale | Dec 10, 2024 | — |
| 4 | Insider transaction | Dec 9, 2024 | Dec 6, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 6, 2024 |
| 144/A | Filing | Dec 9, 2024 | — |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 144 | Notice of proposed sale | Dec 6, 2024 | — |
| 10-Q/A | Amended quarterly report | Dec 6, 2024 | Sep 30, 2024 |
| 144 | Notice of proposed sale | Dec 5, 2024 | — |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 144 | Notice of proposed sale | Dec 4, 2024 | — |
| 144 | Notice of proposed sale | Dec 4, 2024 | — |
| 144 | Notice of proposed sale | Dec 3, 2024 | — |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| 4 | Insider transaction | Nov 21, 2024 | Nov 19, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 19, 2024 |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 14, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 12, 2024 | Nov 9, 2024 |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| 4 | Insider transaction | Oct 17, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 15, 2024 |
| 144 | Notice of proposed sale | Oct 16, 2024 | — |
| 144 | Notice of proposed sale | Oct 15, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 15, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Sep 19, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Sep 19, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Sep 19, 2024 | Sep 17, 2024 |
| 144 | Notice of proposed sale | Sep 18, 2024 | — |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 10, 2024 |
| 144 | Notice of proposed sale | Sep 10, 2024 | — |
| 4 | Insider transaction | Aug 28, 2024 | Aug 26, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671858
- Former names
- Silverback Therapeutics, Inc. (until Nov 8, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.